VYNE

VYNE Therapeutics Inc.

Price

$0.54

return (12m)

21.27%

p/e

-1.25

p/bv

1.09

DIVIDEND YIELD

145.60%

VYNE price

VYNE Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VYNE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

171.67%

3 months

174.45%

1 year

21.27%

2 years

-15.69%

5 years

-96.37%

10 years

0.00%

Fundamentals VYNE

Valuation

P/E

-1.25

Sector -4.39

Industry -5.16

P/BV

1.09

Sector 2.12

Industry 3.07

P/Revenue (PSR)

58.38

Sector 1.92

Industry 2.74

EV/EBITDA

-0.51

Sector -32,939,706.09

Industry -2,818,355.16

EV/EBIT

-0.50

Sector -31,816,414.67

Industry -77,623,296.38

P/EBITDA

-1.10

Sector -1.33

Industry -3.44

P/EBIT

-1.10

Sector -3.84

Industry -5.52

P/Total Assets

1.04

Sector 1.12

Industry 1.15

P/Ativo Circ. Liq.

1.09

Sector -6,896,267.13

Industry -6,000,435.85

P/Cap.Giro

1.09

Sector -717,390.90

Industry -11,460,107.31

EPS

-21.45

Sector -1.08

Industry -0.75

BVPS

24.64

Sector 3.50

Industry 3.67

Efficiency

Gross Margin

100.00%

Sector 42.37%

Industry 51.71%

EBITDA Margin

-4,233.33%

Sector -312.85%

Industry -8.93%

EBIT Margin

-4,244.44%

Sector -193.57%

Industry -21.42%

Operating Margin

-100.00%

Sector -29.26%

Industry -20.41%

Net Profit Margins

-100.00%

Sector -33.61%

Industry -23.36%

Giro Ativos

0.00

Sector 0.12

Industry 0.12

Profitability

ROE

-87.05%

Sector -41.68%

Industry -29.76%

ROA

-82.91%

Sector -32.59%

Industry -8.75%

ROIC

-4,164.80%

Sector -439.00%

Industry -13.28%

Dividends

Dividend yield

145.60%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

20.80

Sector 1.87

Industry 2.65

Dívida Líquida/EBITDA

6.54

Sector -1.64

Industry 9.55

Dívida Líquida/EBIT

6.53

Sector -0.81

Industry 8.48

Dívida Líquida/Patrimônio

-1.01

Sector -0.35

Industry -0.03

Dívida Bruta/Patrimônio

0.00

Sector 0.17

Industry 0.38

Equity/Assets

0.95

Sector 0.41

Industry 0.42

Liabilities/Assets

0.05

Sector 0.45

Industry 0.49

Growth

5Y Revenue CAGR

-13.13%

Sector -

Industry -

5Y Earnings CAGR

-21.80%

Sector -

Industry -

Fundamentals VYNE

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
VYNE	-1.25	1.09	-87.05%	145.60%	$26.86 M	-100.00%
LLY	42.55	34.48	81.02%	0.54%	$1.08 T	34.99%
ISRG	38.26	6.56	17.15%	0.00%	$120.09 B	28.45%
SNY	7.10	1.26	17.79%	4.07%	$105.96 B	14.75%
NVS	23.21	7.06	30.41%	2.00%	$296.12 B	22.50%
TMO	29.78	3.93	13.19%	0.32%	$207.50 B	15.04%
ABT	25.64	3.09	12.06%	0.00%	$160.92 B	13.91%
MDT	22.18	2.13	9.59%	3.43%	$106.51 B	13.20%
GSK	13.15	4.44	33.77%	3.42%	$103.21 B	17.79%
CVS	46.73	1.76	3.78%	2.47%	$137.02 B	0.72%
BSX	18.64	2.57	13.78%	0.00%	$66.45 B	17.29%
TMDX	13.95	4.86	34.80%	0.00%	$2.40 B	27.04%
IDXX	39.73	27.96	70.38%	0.00%	$43.51 B	24.63%
RMD	18.74	4.39	23.41%	1.22%	$28.48 B	27.44%
HCA	12.70	-28.97	-228.14%	0.78%	$86.27 B	8.89%
DHR	33.74	2.57	7.61%	0.54%	$135.09 B	15.95%
SYK	37.64	5.47	14.52%	1.05%	$125.61 B	13.21%
PHG	22.19	1.90	8.56%	3.85%	$25.07 B	5.50%
COHR	117.65	5.01	4.26%	0.00%	$55.16 B	7.10%
INMD	11.06	1.46	13.18%	0.00%	$963.90 M	23.27%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VYNE Historical Dividends

current DY: 145.60%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/21/2026	07/23/2026	19.00000000
Dividends	07/23/2026	07/23/2026	20.10000000

ABOUT VYNE Therapeutics

VYNE Therapeutics Inc.

Average Investor10 user rating

4.0 (2 people)

United States

15 years

Founded: 2011

2018

Time since IPO - 8 years

40

Employees

VYNE Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $26.86 million, with shareholders equity totaling $24.64 million.

The company employs approximately 40 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, VYNE Therapeutics Inc. reported $460.00 Thousand in revenue, generating net income of $-21.45 million.

Key financial metrics include a P/E ratio of -1.25, a price-to-book (P/B) ratio of 1.09, and a trailing twelve-month dividend yield of 145.60%.

The company trades under the ticker VYNE.

Market cap

$26.86 million

Net worth

$24.64 million

$24,640,000.00

Assets

$25.87 million

$25,870,000.00

Total Shares Outstanding

1.00 million

1,000,000

Average Daily Trading Volume

$879.02 Thousand

$879,017.94

Sector

Health

Industry

Pharmaceutical Products

VYNE

VYNE revenue and profits

Financial Results VYNE

DRAG THE FRAME TO SEE MORE DATA

VYNE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$107.64 83,79% (12M)

P/E

46.73

2.47%

ROE

3.78%

P/BV

1.76

CI - Cigna

$288.18 --0,62% (12M)

P/E

11.72

2.13%

ROE

15.39%

P/BV

1.80

CNC - Centene

$63.51 123,71% (12M)

P/E

-4.85

0.00%

ROE

-29.93%

P/BV

1.45

HUM - Humana

$394.56 67,78% (12M)

P/E

41.90

0.67%

ROE

6.06%

P/BV

2.54

SNY - Sanofi

$43.41 --10,42% (12M)

P/E

7.10

4.07%

ROE

17.79%

P/BV

1.26

LLY - Eli Lilly

$1,201.79 49,77% (12M)

P/E

42.55

0.54%

ROE

81.02%

P/BV

34.48

HCA - HCA Healthcare

$385.14 15,96% (12M)

P/E

12.70

0.78%

ROE

-228.14%

P/BV

-28.97

NVS - Novartis

$155.45 34,63% (12M)

P/E

23.21

2.00%

ROE

30.41%

P/BV

7.06